Margaret Dugan - 16 Oct 2025 Form 4 Insider Report for Schrodinger, Inc. (SDGR)

Reporting relationship: Chief Medical Officer
Issuer ticker: SDGR
Reported as of: 16 Oct 2025
Net transaction value: -$29,387
SEC form: 4
Accepted by SEC: 17 Oct 2025, 16:28:13 UTC
Prior SEC filing: 22 May 2025
Next SEC filing: 02 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Donald Shum, as attorney-in-fact for Margaret Dugan

Key filing fact

Margaret Dugan filed Form 4 for Schrodinger, Inc. (SDGR) on 17 Oct 2025.

Key facts

This page summarizes Margaret Dugan's Form 4 filing for Schrodinger, Inc. (SDGR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Oct 2025, 16:28.

Change

Previous filing in this sequence was filed on 22 May 2025.
Current net transaction value: -$29,387.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001909734 Primary reporting owner

Dugan Margaret

Relationship: Chief Medical Officer
Address: C/O SCHRODINGER, INC., 1540 BROADWAY, 24TH FLOOR, NEW YORK
Signature: /s/ Donald Shum, as attorney-in-fact for Margaret Dugan
Signature date: 17 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SDGR transaction

Common Stock

Sale

Transaction value: $29,387
Shares: -1,395
Change %: -5.4%
Price: $21.07
Shares after: 24,574
Date: 16 Oct 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on November 13, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person.

Footnote F2

Includes 20,000 unvested RSUs.